Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Chemotherapy for Primary CNS Lymphoma
NCT00074191Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Jan 2000
- Primary completion
- Oct 2000
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, procarbazine, lomustine, dexamethasone, cytarabine in primary central nervous system lymphoma (PCNSL), sponsored by OHSU Knight Cancer Institute. Started Jan 2000; status: completed.
02
Drugs
methotrexateprocarbazinelomustinedexamethasonecytarabine
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00074191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074191.